Literature DB >> 20023175

Functional importance of the NH2-terminal insertion sequence of lung surfactant protein B.

Shelli L Frey1, Luka Pocivavsek, Alan J Waring, Frans J Walther, Jose M Hernandez-Juviel, Piotr Ruchala, Ka Yee C Lee.   

Abstract

Lung surfactant protein B (SP-B) is required for proper surface activity of pulmonary surfactant. In model lung surfactant lipid systems composed of saturated and unsaturated lipids, the unsaturated lipids are removed from the film at high compression. It is thought that SP-B helps anchor these lipids closely to the monolayer in three-dimensional cylindrical structures termed "nanosilos" seen by atomic force microscopy imaging of deposited monolayers at high surface pressures. Here we explore the role of the SP-B NH(2) terminus in the formation and stability of these cylindrical structures, specifically the distribution of lipid stack height, width, and density with four SP-B truncation peptides: SP-B 1-25, SP-B 9-25, SP-B 11-25, and SP-B 1-25Nflex (prolines 2 and 4 substituted with alanine). The first nine amino acids, termed the insertion sequence and the interface seeking tryptophan residue 9, are shown to stabilize the formation of nanosilos while an increase in the insertion sequence flexibility (SP-B 1-25Nflex) may improve peptide functionality. This provides a functional understanding of the insertion sequence beyond anchoring the protein to the two-dimensional membrane lining the lung, as it also stabilizes formation of nanosilos, creating reversible repositories for fluid lipids at high compression. In lavaged, surfactant-deficient rats, instillation of a mixture of SP-B 1-25 (as a monomer or dimer) and synthetic lung lavage lipids quickly improved oxygenation and dynamic compliance, whereas SP-B 11-25 surfactants showed oxygenation and dynamic compliance values similar to that of lipids alone, demonstrating a positive correlation between formation of stable, but reversible, nanosilos and in vivo efficacy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20023175      PMCID: PMC2838675          DOI: 10.1152/ajplung.00190.2009

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  60 in total

Review 1.  New synthetic surfactant - how and when?

Authors:  Tore Curstedt; Jan Johansson
Journal:  Biol Neonate       Date:  2006-06-01

2.  Common respiratory disorders of the newborn.

Authors:  A E Kopelman; O P Mathew
Journal:  Pediatr Rev       Date:  1995-06

Review 3.  Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society.

Authors:  J Stocks; P H Quanjer
Journal:  Eur Respir J       Date:  1995-03       Impact factor: 16.671

4.  Conformational mapping of the N-terminal segment of surfactant protein B in lipid using 13C-enhanced Fourier transform infrared spectroscopy.

Authors:  L M Gordon; K Y Lee; M M Lipp; J A Zasadzinski; F J Walther; M A Sherman; A J Waring
Journal:  J Pept Res       Date:  2000-04

5.  Formation of three-dimensional protein-lipid aggregates in monolayer films induced by surfactant protein B.

Authors:  S Krol; M Ross; M Sieber; S Künneke; H J Galla; A Janshoff
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

6.  Multilayer formation upon compression of surfactant monolayers depends on protein concentration as well as lipid composition. An atomic force microscopy study.

Authors:  Robert V Diemel; Margot M E Snel; Alan J Waring; Frans J Walther; Lambert M G van Golde; Günther Putz; Henk P Haagsman; Joseph J Batenburg
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

7.  Dimeric N-terminal segment of human surfactant protein B (dSP-B(1-25)) has enhanced surface properties compared to monomeric SP-B(1-25).

Authors:  E J Veldhuizen; A J Waring; F J Walther; J J Batenburg; L M van Golde; H P Haagsman
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

8.  Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids.

Authors:  P Berggren; T Curstedt; G Grossman; R Nilsson; B Robertson
Journal:  Exp Lung Res       Date:  1985       Impact factor: 2.459

9.  Phosphatidylcholine molecular species of calf lung surfactant.

Authors:  M C Kahn; G J Anderson; W R Anyan; S B Hall
Journal:  Am J Physiol       Date:  1995-11

10.  Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation.

Authors:  Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2008-11       Impact factor: 10.793

View more
  11 in total

1.  Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study.

Authors:  Ann B Nguyen; Anand Rohatgi; Christine K Garcia; Colby R Ayers; Sandeep R Das; Susan G Lakoski; Jarett D Berry; Amit Khera; Darren K McGuire; James A de Lemos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-04       Impact factor: 8.311

Review 2.  Structure-function correlations of pulmonary surfactant protein SP-B and the saposin-like family of proteins.

Authors:  Bárbara Olmeda; Begoña García-Álvarez; Jesús Pérez-Gil
Journal:  Eur Biophys J       Date:  2012-09-21       Impact factor: 1.733

3.  Investigating the effect of particle size on pulmonary surfactant phase behavior.

Authors:  Akihisa T Kodama; Chin-Chang Kuo; Thomas Boatwright; Michael Dennin
Journal:  Biophys J       Date:  2014-10-07       Impact factor: 4.033

4.  KL₄ peptide induces reversible collapse structures on multiple length scales in model lung surfactant.

Authors:  Niels Holten-Andersen; J Michael Henderson; Frans J Walther; Alan J Waring; Piotr Ruchala; Robert H Notter; Ka Yee C Lee
Journal:  Biophys J       Date:  2011-12-20       Impact factor: 4.033

5.  Lipid polymorphism induced by surfactant peptide SP-B(1-25).

Authors:  R Suzanne Farver; Frank D Mills; Vijay C Antharam; Janetricks N Chebukati; Gail E Fanucci; Joanna R Long
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

6.  Lung surfactant protein SP-B promotes formation of bilayer reservoirs from monolayer and lipid transfer between the interface and subphase.

Authors:  Svetlana Baoukina; D Peter Tieleman
Journal:  Biophys J       Date:  2011-04-06       Impact factor: 4.033

7.  Effects of the lung surfactant protein B construct Mini-B on lipid bilayer order and topography.

Authors:  Dharamaraju Palleboina; Alan J Waring; Robert H Notter; Valerie Booth; Michael Morrow
Journal:  Eur Biophys J       Date:  2012-08-19       Impact factor: 1.733

8.  Role of the N-terminal seven residues of surfactant protein B (SP-B).

Authors:  Mahzad Sharifahmadian; Muzaddid Sarker; Dharamaraju Palleboina; Alan J Waring; Frans J Walther; Michael R Morrow; Valerie Booth
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

9.  Design of Surfactant Protein B Peptide Mimics Based on the Saposin Fold for Synthetic Lung Surfactants.

Authors:  Frans J Walther; Larry M Gordon; Alan J Waring
Journal:  Biomed Hub       Date:  2016-11-16

10.  Surfactant protein C peptides with salt-bridges ("ion-locks") promote high surfactant activities by mimicking the α-helix and membrane topography of the native protein.

Authors:  Frans J Walther; Alan J Waring; José M Hernández-Juviel; Piotr Ruchala; Zhengdong Wang; Robert H Notter; Larry M Gordon
Journal:  PeerJ       Date:  2014-07-15       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.